The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.

Latest News

Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer
Multicenter Study Shows Merits of AI-Powered Ultrasound Assessment for Detecting Ovarian Cancer

January 3rd 2025

Adjunctive AI offered greater than seven percent increases in sensitivity, specificity, and accuracy for ultrasound detection of ovarian cancer in comparison to unassisted clinicians who lacked ultrasound expertise, according to findings from new international multicenter research.

Radiologists Outliving Radiology
Radiologists Outliving Radiology

December 9th 2024

FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection

November 20th 2024

New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging

November 18th 2024

FDA Clears AI Software for Fetal Heart Ultrasound Assessment
FDA Clears AI Software for Fetal Heart Ultrasound Assessment

November 18th 2024

Video Interviews
Latest CME Events & Activities

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

View More

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

More News

© 2025 MJH Life Sciences

All rights reserved.